Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey M Harris

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 31, 2011
Development of the Asthma Control Composite outcome measure to predict omalizumab responseJeffrey M Harris, Dennis A Wong, Amy V Kapp
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2002
Ovarian and papillary-serous peritoneal carcinoma: pilot study with thalidomideN Abramson, P K Stokes, Mathew Luke, et al.
The Journal of Allergy and Clinical Immunology|October 26, 2018
Elevated IgE M1 prime transcripts in nasal tissues in patients with nasal polyps and asthmaHeleen Scheerens, Ashley Smith, Olga Li, et al.
Clinical Immunology (Orlando, Fla.)|June 1, 2005
Recent thymic emigrants and subsets of naive and memory T cells in the circulation of patients with head and neck cancerIris Kuss, Carsten Schaefer, Tony E Godfrey, et al.
Clinical Immunology (Orlando, Fla.)|May 12, 2005
Multiparameter evaluation of human thymic function: interpretations and caveatsJeffrey M Harris, Mette D Hazenberg, Jean-François Poulin, et al.
The Journal of Allergy and Clinical Immunology|July 30, 2015
The airway microbiome in patients with severe asthma: Associations with disease features and severityYvonne J Huang, Snehal Nariya, Jeffrey M Harris, et al.
Pulmonary Pharmacology & Therapeutics|June 24, 2021
A phase 1, randomized study to evaluate safety, tolerability, and pharmacokinetics of GDC-3280, a potential novel anti-fibrotic small molecule, in healthy subjectsDorothy Cheung, Alice Fong, Han Ting Ding, et al.
American Journal of Respiratory and Critical Care Medicine|July 1, 2017
Increased IgE<sup>+</sup> B Cells in Sputum, but Not Blood, Bone Marrow, or Tonsils, after Inhaled Allergen Challenge in Subjects with AsthmaJohn-Paul Oliveria, Brittany M Salter, Jonathan MacLean, et al.
The Journal of Allergy and Clinical Immunology|August 28, 2016
A randomized trial of quilizumab in adults with refractory chronic spontaneous urticariaJeffrey M Harris, Christopher R Cabanski, Heleen Scheerens, et al.
American Journal of Respiratory and Critical Care Medicine|March 9, 2013
Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA studyNicola A Hanania, Sally Wenzel, Karin Rosén, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 31, 2011
Development of the Asthma Control Composite outcome measure to predict omalizumab responseJeffrey M Harris, Dennis A Wong, Amy V Kapp
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2002
Ovarian and papillary-serous peritoneal carcinoma: pilot study with thalidomideN Abramson, P K Stokes, Mathew Luke, et al.
The Journal of Allergy and Clinical Immunology|October 26, 2018
Elevated IgE M1 prime transcripts in nasal tissues in patients with nasal polyps and asthmaHeleen Scheerens, Ashley Smith, Olga Li, et al.
Clinical Immunology (Orlando, Fla.)|June 1, 2005
Recent thymic emigrants and subsets of naive and memory T cells in the circulation of patients with head and neck cancerIris Kuss, Carsten Schaefer, Tony E Godfrey, et al.
Clinical Immunology (Orlando, Fla.)|May 12, 2005
Multiparameter evaluation of human thymic function: interpretations and caveatsJeffrey M Harris, Mette D Hazenberg, Jean-François Poulin, et al.
The Journal of Allergy and Clinical Immunology|July 30, 2015
The airway microbiome in patients with severe asthma: Associations with disease features and severityYvonne J Huang, Snehal Nariya, Jeffrey M Harris, et al.
Pulmonary Pharmacology & Therapeutics|June 24, 2021
A phase 1, randomized study to evaluate safety, tolerability, and pharmacokinetics of GDC-3280, a potential novel anti-fibrotic small molecule, in healthy subjectsDorothy Cheung, Alice Fong, Han Ting Ding, et al.
American Journal of Respiratory and Critical Care Medicine|July 1, 2017
Increased IgE<sup>+</sup> B Cells in Sputum, but Not Blood, Bone Marrow, or Tonsils, after Inhaled Allergen Challenge in Subjects with AsthmaJohn-Paul Oliveria, Brittany M Salter, Jonathan MacLean, et al.
The Journal of Allergy and Clinical Immunology|August 28, 2016
A randomized trial of quilizumab in adults with refractory chronic spontaneous urticariaJeffrey M Harris, Christopher R Cabanski, Heleen Scheerens, et al.
American Journal of Respiratory and Critical Care Medicine|March 9, 2013
Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA studyNicola A Hanania, Sally Wenzel, Karin Rosén, et al.
Pageof 3